Tomoe Fujita*, Yuji Kumagai, Yasuhiro Ikeda, Naoya Inamura, Tomonori
Iwata, Michiko Ogino and Masataka Majima
Department of Pharmacology, Kitasato University School of Medicine, 1-15-1
Kitasato, Sagamihara-shi, Kanagawa 228-8555, Japan
*Corresponding author.ÊÊFAX:+81-42-778-8441
E-mail: twata@med.kitasato-u.ac.jp
Abstract: This study examined whether the renal kallikrein-kinin
system (KKS) is involved with furosemide-induced natriuresis in rats. Intravenous
administration of furosemide (10Êmg/kg) to anesthetized rats infused with
physiological saline (saline) increased renal KK excretion as well as urine
volume and urinary excretions of sodium, chloride and potassium. The change
in the increase of renal KK excretion by furosemide at a dose of 1.0Êmg/kg
relative to the control was larger than that of urine volume. Pretreatment
with a B2-receptor antagonist, 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline
(FR173657, 100Êmg/kg), significantly inhibited the furosemide-induced natriuresis
Keywords: B2-receptor antagonist, FR173657, Furosemide, Natriuresis,
Renal kallikrein
Copyright© The Japanese Pharmacological Society 2000
[Back to TOC]